Search results for "VASCULAR RISK"

showing 10 items of 328 documents

Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in …

2012

Abstract Background Blood coagulation is an essential determinant of coronary artery disease (CAD). Soluble Endothelial Protein C Receptor (sEPCR) may be a biomarker of a hypercoagulable state. We prospectively investigated the relationship between plasma sEPCR levels and the risk of cardiovascular events (CVE). Methods We measured baseline sEPCR levels in 1673 individuals with CAD (521 with acute coronary syndrome [ACS] and 1152 with stable angina pectoris [SAP]) from the AtheroGene cohort. During a median follow up of 3.7 years, 136 individuals had a CVE. In addition, 891 of these CAD patients were genotyped for the PROCR rs867186 (Ser219Gly) variant. Results At baseline, sEPCR levels wer…

Malelcsh:Internal medicinemedicine.medical_specialtyAcute coronary syndromelcsh:QH426-470Cardiovascular risk factorsReceptors Cell Surface[SDV.GEN] Life Sciences [q-bio]/Genetics030204 cardiovascular system & hematologyBiology[SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human geneticsPolymorphism Single NucleotideCoronary artery diseaseEndothelial protein C receptorAngina PectorisCoronary artery disease03 medical and health sciences0302 clinical medicineAntigens CDRisk FactorsInternal medicineGeneticsmedicineHumansGenetics(clinical)Acute Coronary Syndromelcsh:RC31-1245GeneGenetics (clinical)030304 developmental biology0303 health sciencesEndothelial protein C receptor[SDV.GEN]Life Sciences [q-bio]/Geneticsmedicine.diseaselcsh:GeneticsCoagulation[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsCardiovascular DiseasesImmunologyCardiologyBiomarker (medicine)Female\BiomarkersProtein CResearch Articlemedicine.drugHaemostasisProtein C
researchProduct

Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE s…

2010

AimsLimited information is available on office and ambulatory blood pressure (BP) control as well as on cardiovascular (CV) risk profile in treated hypertensive patients living in central and eastern European countries.Methods and resultsIn 2008, a survey on 7860 treated hypertensive patients followed by non-specialist or specialist physicians was carried out in nine central and eastern European countries (Albania, Belarus, Bosnia, Czech Republic, Latvia, Romania, Serbia, Slovakia, and Ukraine). Cardiovascular risk assessment was based on personal history, clinic BP values, as well as target organ damage evaluation. Patients had a mean (±SD) age of 60.1 ± 11 years, and the majority of them …

Malemedicine.medical_specialtyAmbulatory blood pressureCross-sectional studyRisk AssessmentRisk FactorsInternal medicinemedicineAlbuminuriaHumansBlood pressure cardiovascular risk risk factors hypertensionEurope EasternStrokeAntihypertensive AgentsAgedbusiness.industryMiddle Agedmedicine.diseaseSurgeryEastern europeanEuropeBlood pressureCross-Sectional StudiesCardiovascular DiseasesAmbulatoryHypertensionElectrocardiography AmbulatoryMicroalbuminuriaDrug Therapy CombinationFemaleCardiology and Cardiovascular MedicineRisk assessmentbusinessEuropean heart journal
researchProduct

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.

2014

Background Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. Methods A prospective study of 8 months duration in 64 patients with type-2 diabetes and no prior history of coronary artery disease evaluated whether adding liraglutide to metformin affects carotid IMT, measured by color doppler ultrasound. Results After 8 months, fasting glucose decreased by 2.1 mmol/l and HbA1c by 1.9% (p < 0.01 for all). Liraglutide reduced total-cholesterol and triglycerides by 10%, and LDL-cholesterol by 19%, whereas HDL-cholester…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPilot ProjectsType2 diabetesType 2 diabetesCarotid Intima-Media ThicknessCoronary artery diseaseGlucagon-Like Peptide 1Internal medicineDiabetes mellitusLiraglutide Carotid intima-media thickness Cardiovascular risk Type2 diabetesmedicineHumansHypoglycemic AgentsProspective Studiescardiovascular diseasesProspective cohort studyGlycemicAgedOriginal Investigationbusiness.industryLiraglutideLiraglutideMiddle Agedmedicine.diseaseCardiovascular risk3. Good healthMetforminEndocrinologyIntima-media thicknessDiabetes Mellitus Type 2Cardiologycardiovascular systemFemalebusinessCardiology and Cardiovascular Medicinemedicine.drug
researchProduct

Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction

2006

We sought to investigate the association between increased levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and total plasma homocysteinemia (tHcy) in patients with acute myocardial infarction (AMI).In 138 patients hospitalized for AMI24 h on admission, serum levels of ADMA, its symmetric stereoisomer (SDMA) and tHcy were measured.ADMA was positively associated with SDMA (p0.001) and tHcy (p=0.03) but not with estimated glomerular filtration rates (eGFR, p=0.96), while tHcy strongly correlated with eGFR (p=0.002) and SDMA (p0.001). By multiple linear regression, SDMA but not ADMA was independently associated with tHcy (p=0.005).Our findings sugges…

Malemedicine.medical_specialtyHyperhomocysteinemiaHomocysteineClinical BiochemistryCardiovascular risk factorsHyperhomocysteinemiaMyocardial InfarctionRenal functionArginineStatistics Nonparametricchemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansIn patientcardiovascular diseasesMyocardial infarctionHomocysteineAgedbusiness.industryStereoisomerismGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologychemistryRisk indicatorCardiologyRegression AnalysisFemalebusinessAsymmetric dimethylarginineClinical Biochemistry
researchProduct

Cardiovascular risk factor in MPN patients

2020

Malemedicine.medical_specialtyMyeloproliferative DisordersHematologybusiness.industryThrombosisHematologyMiddle AgedCardiovascular riskSettore MED/15 - Malattie Del SangueText miningCardiovascular DiseasesHeart Disease Risk FactorsInternal medicineHumansMedicineFemaleRisk factorCardiology and Cardiovascular MedicinebusinessAgedJournal of Thrombosis and Thrombolysis
researchProduct

Stroke associated with giant cell arteritis: a population-based study

2014

Background Giant cell arteritis (GCA) is the most common vasculitis in people ≥50 years and can be associated with stroke. We aimed to evaluate the epidemiology and characteristics of stroke in patients with GCA. Methods All patients with a biopsy-proven diagnosis of GCA were identified among residents of the city of Dijon, France (152 000 inhabitants), between 2001 and 2012 using a prospective database. Among these, patients who suffered from stroke were retrieved by crossing data from the population-based Dijon Stroke Registry. Demographics and clinical features were recorded. We considered that the stroke was GCA-related if the stroke revealed GCA or occurred between the onset of symptom…

Malemedicine.medical_specialtyPediatricsGiant Cell ArteritisPopulationVascular riskAge DistributionSex Factorsimmune system diseasesInternal medicineEpidemiologymedicineHumansProspective StudiesRegistriescardiovascular diseasesskin and connective tissue diseaseseducationStrokeAgedAged 80 and overeducation.field_of_studybusiness.industryIncidenceMiddle Agedmedicine.diseaseRheumatologyStrokePopulation based studyPsychiatry and Mental healthGiant cell arteritiscardiovascular systemFemaleSurgeryFranceNeurology (clinical)VasculitisbusinessJournal of Neurology, Neurosurgery &amp; Psychiatry
researchProduct

Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pres…

2019

OBJECTIVE: Hyperuricemia has been associated with high blood pressure (BP) values, diabetes mellitus, metabolic syndrome and chronic kidney disease (CKD). In the present study, we assessed the gender-related relationships between serum uric acid (SUA) and cardionephrometabolic variables in central and east European hypertensive patients. METHODS: A total of 3206 treated hypertensive patients with available SUA levels from the BP-CARE study was analyzed. Correlations among SUA, BP values, BP control, diabetes mellitus, metabolic syndrome and CKD were performed according to gender. RESULTS: Twenty-five percent of the whole population showed hyperuricemia (28% in women and 23% in men). These p…

Malemedicine.medical_specialtyPhysiologyCross-sectional studyBlood PressureComorbidityHyperuricemia030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSex FactorsRisk FactorsDiabetes mellitusInternal medicineInternal MedicinemedicineDiabetes MellitusPrevalenceHumans030212 general & internal medicineHyperuricemiaEurope EasternRenal Insufficiency ChronicAgedMetabolic Syndromebusiness.industrynutritional and metabolic diseasesMiddle AgedCardiovascular riskKidney damagemedicine.diseaseComorbidityUric AcidBlood pressureCross-Sectional StudieschemistryHypertensionUric acidFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessKidney diseaseJournal of hypertension
researchProduct

Polyphenol intake and cardiovascular risk in the PREDIMED-Plus trial. A comparison of different risk equations

2022

Abstract Introduction and objectives Quantification of cardiovascular risk has been based on scores such as Framingham, Framingham-REGICOR, SCORE or Life's Simple 7 (LS7). In vitro, animal, and randomized clinical studies have shown that polyphenols may provide benefits to the vascular system and reduce the inflammatory response. However, some clinical-epidemiological studies have yielded inconsistent results. Our aim was to assess the possible association between intake of the various polyphenol classes and established cardiovascular scores. Methods This cross-sectional analysis involved 6633 PREDIMED-Plus study participants. Food polyphenol content was estimated by a semiquantitative food…

Malemedicine.medical_specialtyPolifenolesRiesgo cardiovascularInflammatory responseCardiovascular scoreRisk FactorsInternal medicineLinear regressionmedicineHumansEcuación cardiovascularTotal energyFramingham Risk Scorebusiness.industryPolyphenolsfood and beveragesFood frequency questionnaireGeneral MedicineCardiovascular riskPredimedResidual methodCross-Sectional StudiesCardiovascular DiseasesHeart Disease Risk FactorsPolyphenolFemalebusinessRevista Española de Cardiología (English Edition)
researchProduct

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSC…

2018

Abstract Aims Resting heart rate (RHR) has been shown to be associated with cardiovascular outcomes in various conditions. It is unknown whether different levels of RHR and different associations with cardiovascular outcomes occur in patients with or without diabetes, because the impact of autonomic neuropathy on vascular vulnerability might be stronger in diabetes. Methods and results We examined 30 937 patients aged 55 years or older with a history of or at high risk for cardiovascular disease and after myocardial infarction, stroke, or with proven peripheral vascular disease from the ONTARGET and TRANSCEND trials investigating ramipril, telmisartan, and their combination followed for a m…

Malemedicine.medical_specialtyRestHeart failure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineHeart RateRisk FactorsInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansMyocardial infarctionProspective StudiesONTARGETStrokeProportional hazards modelbusiness.industryHazard ratioDiabetesAtrial fibrillation030229 sport sciencesMiddle Agedmedicine.diseaseCardiovascular riskMyocardial infarctionBlood pressureCardiovascular DiseasesHeart Disease Risk FactorsHeart failureCardiologyBlood pressureFemaleCardiology and Cardiovascular MedicinebusinessTRANSCENDEuropean heart journal
researchProduct

Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk

2015

OBJECTIVE This study was designed to evaluate the relationship among circulating adiponectin (ADPN), left ventricular mass (LVM) and cardiometabolic comorbidities in subjects at higher global cardiovascular risk (score of “ Cuore Project “) METHODS. 115 consecutive subjects were grouped according to normal or low ADPN levels. Left ventricular internal diameter (LVID/h), total LV mass (LVM), LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters, by pulsed-wave Doppler were calculated. RESULTS Low-ADPN subjects were characterized by a significant higher prevalence of some cardiometabolic comorbidities (obesity, visceral obesity, dia…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaCardiac VolumeHeart VentriclesCardiac VolumeLeft ventricular hypertrophyRisk AssessmentVentricular Function LeftLeft ventricular massRisk FactorsInternal medicinePrevalencemedicineHumansEchocardiography Doppler PulsedVentricular functionAdiponectinbusiness.industryStroke VolumeAdiponectinGlobal cardiovascular riskleft ventricular hypertrophyGeneral MedicineStroke volumeMiddle AgedPrognosismedicine.diseaseItalyCardiovascular DiseasesCardiologyFemaleAdiponectinCardiology and Cardiovascular MedicinebusinessBiomarkersActa Cardiologica
researchProduct